- This international agreement aims to build strong sectoral and cross-organizational collaborations to design novel methodologies to tackle future epidemics and infectious diseases.
- The collaboration will strengthen academic-industry partnerships and augment global efforts to combat infectious diseases.
- It will leverage academic and industry strengths to advance the science of vaccines and biotherapeutics.
- Dr. Krishna Ella, Executive Chairman at Bharat Biotech, expressed excitement about the new opportunities to strengthen their shared vision, leverage the prowess of education and research capabilities to help build a healthier universe, and improve people’s lives by developing safer vaccine platforms.
Question:
Q.1 What is the main aim of the BBIL & Sydney University MoU?a. To advance vaccine research initiatives
b. To develop new pharmaceutical drugs
c. To collaborate on agricultural research
d. To collaborate on space research
